{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:19Z","timestamp":1786120279067,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/wnf.0b013e3182285e2d","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T19:00:11Z","timestamp":1317754811000},"page":"195-198","source":"Crossref","is-referenced-by-count":13,"title":["Safety and Efficacy of Long-Term Disulfiram Aftercare"],"prefix":"10.1097","volume":"34","author":[{"given":"Jochen","family":"Mutschler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclseren","family":"Dirican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gutzeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Grosshans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210203","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pharmthera.2006.02.001","article-title":"Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.","volume":"111","author":"Heilig","year":"2006","journal-title":"Pharmacol Ther"},{"key":"R2-5-20210203","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tips.2007.12.005","article-title":"Drugs for relapse prevention of alcoholism: ten years of progress.","volume":"29","author":"Spanagel","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"R3-5-20210203","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2174\/138161210791516431","article-title":"Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment.","volume":"16","author":"Krampe","year":"2010","journal-title":"Curr Pharm Des"},{"key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0447.1991.tb03126.x","article-title":"Long-term use of aversive drugs in outpatient alcoholism treatment.","volume":"84","author":"Ojehagen","year":"1991","journal-title":"Acta Psychiatr Scand"},{"key":"R5-5-20210203","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1521-0391.2003.tb00652.x","article-title":"Disulfiram treatment for alcoholism in severe mental illness.","volume":"12","author":"Mueser","year":"2003","journal-title":"Am J Addict"},{"key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1530-0277.2006.00013.x","article-title":"Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome.","volume":"30","author":"Krampe","year":"2006","journal-title":"Alcohol Clin Exp Res"},{"key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/WNF.0b013e3181fc9362","article-title":"Urinary ethylglucuronide assessment in patients treated with disulfiram: a tool to improve verification of abstention and safety.","volume":"33","author":"Mutschler","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/alcalc\/agq017","article-title":"Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.","volume":"45","author":"Diehl","year":"2010","journal-title":"Alcohol Alcohol"},{"key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"R10-5-20210203","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","article-title":"Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study.","volume":"60","author":"Kiefer","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R11-5-20210203","first-page":"243","article-title":"Recent results in relapse prevention of alcoholism with disulfiram in German.","volume":"22","author":"Mutschler","year":"2008","journal-title":"Neuropsychiatr"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/jama.1986.03380110055026","article-title":"Disulfiram treatment of alcoholism. A Veterans Administration cooperative study.","volume":"256","author":"Fuller","year":"1986","journal-title":"JAMA"},{"key":"R14-5-20210203","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/WNF.0b013e3182216fd5","article-title":"Experienced acetaldehyde reaction does not improve treatment response in outpatients treated with supervised disulfiram.","volume":"34","author":"Mutschler","year":"2011","journal-title":"Clin Neuropharmacol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-201109000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:24:48Z","timestamp":1786047888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201109000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3182285e2d","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}